Ongoing risk stratification trials: the primary prevention of sudden death.
This paper reviews three ongoing risk stratification trials: the Coronary Artery Bypass Grafting-Patch Trial (CABG-Patch), the Multicenter Automatic Implantable Defibrillator Trial (MADIT), and the Multicenter Unsustained Tachycardia Trial (MUSTT).
Buxton
A E
AE
Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D006801:Humans; D013610:Tachycardia / Q000517:prevention & control / Q000628:therapy*
D000889:Anti-Arrhythmia Agents